- Medical Devices
- Thursday, 19 Sep 2019
NGS Makes Sequence Based Gene Expression Analysis a “Digital” Alternative to Analog Techniques
The growth of the infusion pumps market is attributed to the declining prices of sequencing services as well as various technological advancements in the field of sequencing during the recent years. Advancement in the field of molecular biology has equally enhanced the sequencing procedures. Many industry players have come up with innovative NGS technology in last few years. For instance, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION. Additionally, three advances NSG systems that dominate the market includes Roche GS FLX (454), Illumina HiSeq 2000 (Solexa) and AB SOLiD (Agencourt).
Some of the major primary and secondary sources for infusion pumps included in the report are World Health Organization (WHO), Organisation for Economic Co-operation (OECD), National Research Foundation (NRF), International Diabetes Federation (IDF), Canadian Institutes of Health Research (CIHR) and others.
Further modification and automation of this process continued to increase sequencing data and time reduction. Thereby allowing researchers to reach major milestones in the Human Genome Project. NGS makes sequence based gene expression analysis a “digital” alternative to analog techniques. Advancement in genome sequencing has made the sequencing easy and accurate.
In the recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduces to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. Major market players such as Illumina and Roche have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.
Global infusion pumps market, based on product was segmented as, consumables, services and platforms. In 2017, consumables segment held the largest share by the market, by product. This is mainly attributed since these consumables are used at every stage of sequencing.
Global infusion pumps market, based on application was segmented as, diagnostics, drug discovery, precision medicine, and other applications. In 2017, diagnostics held the largest share of market, by application.
Global infusion pumps market, based on end user was segmented as, academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinics, and other end users. In 2017, academic & research institutes held the largest share of market, by end user. In addition, the hospitals & clinics segment is also anticipated to witness a significant growth, during the forecast period.
Related Industry Updates
Europe Skin Aesthetic Devices Market to Witness Stunning Growth by 2027
Feb 17, 2021
Platelet Rich Plasma (PRP) Tubes Market is expected to reach US$ 1,640.94 million by 2028
Jan 11, 2023
Gynecology Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Therapeutics (Hormonal Therapy and Non-Hormonal Therapy); Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, and Contraception); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
Apr 20, 2021
Global Hospital Mobile X-Ray Market 2021 Trending News,Industry Analysis, Size, Share, Growth, Trends and Forecast to 2027| IDETEC MEDICAL IMAGING, Koninklijke Philips N.V., SternMed GmbH, DMS Imaging, Carestream Health Inc.
Apr 22, 2021
Lab Automation Market Will Escalate Rapidly in the Near Future
Feb 24, 2021
Post-Acute Care Market is expected to reach US$ 1,186.29 billion by 2030
Nov 29, 2023
Europe Surety Market Emerging Technological Growth, Future Growth and Business Opportunities 2027
Apr 08, 2021